logo
logo

Strateos Closes $56 Million Series B Financing To Accelerate The Roll-Out Of Its Smartlab Of The Future Platform

Jun 08, 2021•about 4 years ago

Amount Raised

$56 Million

Round Type

series b

Menlo Park

Description

Strateos, Inc., a pioneer in the development of remote access laboratories and lab control software for life science research, today announced the closing of its $56.1 million Series B financing led by DCVC and Lux Capital with participation from new investors including Eli Lilly and Company, Ally Bridge Group, Black Diamond Ventures, Mack & Co., LLC, and Castor Ventures. With this financing, Strateos will continue to drive innovations on its SmartLab PlatformTM, which integrates data generation and AI-enablement with its unique and flexible automation to accelerate pharmaceutical and synthetic biology R&D.

Company Information

Company

Strateos

Location

Menlo Park, California, United States

About

Strateos is a pioneer in the development of remote access laboratories and lab control software for life science discovery. Our mission is to create new knowledge driven by data, computation, automation, and high-throughput robotics with the goal of fundamentally advancing the life sciences. The Strateos SmartLab Platform™ helps scientists more efficiently and reproducibly design, run, and analyze experiments to achieve new and faster scientific discoveries. For more information, please visit www.strateos.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech